BSE · VINRKLB
Rekvina Laboratories Ltd
₹41.72
-0.67%
Rekvina Laboratories Ltd, an Healthcare business, is currently loss-making on a trailing basis and has a subdued return on equity.
Market Cap
—
P/E Ratio
-417.20
P/B Ratio
—
ROE
4.93%
ROCE
4.93%
Dividend Yield
—
52W High
₹46.65
52W Low
₹4.50
Quarterly financials
| Metric | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 | Q1 2025-26 |
|---|---|---|---|---|
| Revenue | 72.36 L | 34.56 L | 19.62 L | Rs 0 |
| Net Profit | -6.05 L | -12.39 L | -3.49 L | -3.54 L |
| EPS | -0.10 | -0.21 | -0.06 | -0.06 |
| Operating Profit | -6.05 L | -12.39 L | -3.49 L | -3.54 L |
Shareholding pattern
Shareholding pattern for this stock hasn't been ingested yet — check back soon.
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 30 Apr 2014 | Split | Stock Split From Rs.10/- to Rs.5/- |
| 04 Sep 2003 | Dividend | NIL Dividend - Rs. - 0.0000 |
| 04 Sep 2002 | Dividend | NIL Dividend - Rs. - 0.0000 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.